Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Oncogene ; 36(4): 570-584, 2017 01 26.
Article in English | MEDLINE | ID: mdl-27345406

ABSTRACT

Glioblastoma Multiforme (GBM) is characterized by high cancer cell heterogeneity and the presence of a complex tumor microenvironment. Those factors are a key obstacle for the treatment of this tumor type. To model the disease in mice, the current strategy is to grow GBM cells in serum-free non-adherent condition, which maintains their tumor-initiating potential. However, the so-generated tumors are histologically different from the one of origin. In this work, we performed high-throughput marker expression analysis and investigated the tumorigenicity of GBM cells enriched under different culture conditions. We identified a marker panel that distinguished tumorigenic sphere cultures from non-tumorigenic serum cultures (high CD56, SOX2, SOX9, and low CD105, CD248, αSMA). Contrary to previous work, we found that 'mixed cell cultures' grown in serum conditions are tumorigenic and express cancer stem cell (CSC) markers. As well, 1% serum plus bFGF and TGF-α preserved the tumorigenicity of sphere cultures and induced epithelial-to-mesenchymal transition gene expression. Furthermore, we identified 12 genes that could replace the 840 genes of The Cancer Genome Atlas (TCGA) used for GBM-subtyping. Our data suggest that the tumorigenicity of GBM cultures depend on cell culture strategies that retain CSCs in culture rather than the presence of serum in the cell culture medium.


Subject(s)
Carcinogenesis/metabolism , Mesenchymal Stem Cells/metabolism , Neoplastic Stem Cells/metabolism , Animals , Cell Culture Techniques , Cell Line, Tumor , Humans , Mice
2.
Genes Dev ; 12(19): 3059-73, 1998 Oct 01.
Article in English | MEDLINE | ID: mdl-9765207

ABSTRACT

The prl1 mutation localized by T-DNA tagging on Arabidopsis chromosome 4-44 confers hypersensitivity to glucose and sucrose. The prl1 mutation results in transcriptional derepression of glucose responsive genes defining a novel suppressor function in glucose signaling. The prl1 mutation also augments the sensitivity of plants to growth hormones including cytokinin, ethylene, abscisic acid, and auxin; stimulates the accumulation of sugars and starch in leaves; and inhibits root elongation. PRL1 encodes a regulatory WD protein that interacts with ATHKAP2, an alpha-importin nuclear import receptor, and is imported into the nucleus in Arabidopsis. Potential functional conservation of PRL1 homologs found in other eukaryotes is indicated by nuclear localization of PRL1 in monkey COS-1 cells and selective interaction of PRL1 with a nuclear protein kinase C-betaII isoenzyme involved in human insulin signaling.


Subject(s)
Arabidopsis Proteins , Arabidopsis/genetics , Carrier Proteins/physiology , Glucose/physiology , Intracellular Signaling Peptides and Proteins , Nuclear Proteins/physiology , Plant Growth Regulators/physiology , Plant Proteins , Amino Acid Sequence , Arabidopsis/physiology , Carrier Proteins/genetics , Cytokinins/physiology , Gene Expression Regulation, Plant , Humans , Isoenzymes/metabolism , Karyopherins , Molecular Sequence Data , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Kinase C/metabolism , Protein Kinase C beta , Seeds/growth & development , Seeds/metabolism , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL